Japanese Commercial Services Stock News

Transgene and NEC (TSE:6701) have entered a license agreement to advance an individualized neoantigen cancer vaccine. The collaboration will use NEC's AI platform to support clinical development of the personalized therapeutic vaccine. The agreement includes an equity investment by NEC in Transgene, highlighting the financial commitment behind the partnership. For NEC, better known for IT services, networking and AI solutions, this move highlights an expanded focus on healthcare technology...

As global markets experience a relief rally amid easing geopolitical tensions, Asian indices have shown resilience, buoyed by optimism in key sectors such as technology and consumer goods. In this environment, growth companies with high insider ownership often attract attention due to the perceived alignment of interests between management and shareholders, suggesting confidence in long-term potential despite market uncertainties.

Last week, you might have seen that COSMOS Pharmaceutical Corporation ( TSE:3349 ) released its quarterly result to the...

Why Mitsubishi UFJ Financial Group (TSE:8306) is on investor radar today Mitsubishi UFJ Financial Group (TSE:8306) is drawing fresh attention after recent share price moves, with the stock showing a mix of gains over the past month and softer performance over the past 3 months. See our latest analysis for Mitsubishi UFJ Financial Group. The recent 10.31% 1 month share price return, together with a 14.16% year to date share price gain and very large 5 year total shareholder return, points to...

As global markets react positively to a U.S.-Iran ceasefire and declining oil prices, investor sentiment has improved, leading to notable gains across major indices such as the Nasdaq Composite and S&P 500. Amid this optimistic backdrop, uncovering lesser-known stocks with strong fundamentals and growth potential can be particularly rewarding for investors seeking opportunities in an environment marked by geopolitical shifts and technological advancements.

S-Pool (TSE:2471) opened Q1 2026 with revenue of ¥5,938 million and a basic EPS loss of ¥0.87, setting a cautious tone after a profitable FY2025. The company has seen quarterly revenue move from ¥7,375 million in Q4 2024 to ¥6,131 million in Q1 2025 and then to ¥5,938 million in Q1 2026, alongside EPS shifting from ¥13.32 in Q4 2024 to ¥1.24 in Q1 2025 and into a small loss this quarter. This puts the focus firmly on how margins are holding up through this reset. See our full analysis for...

NOMURA Holdings (TSE:9716) has reported its FY 2026 fourth quarter revenue at ¥41,463 million and basic EPS at ¥23.42, while trailing twelve month EPS is ¥81.86 on revenue of ¥162,679 million and net income of ¥9,134 million. The company’s quarterly revenue moved from ¥56,022 million in Q4 FY 2025 to ¥41,463 million in Q4 FY 2026, with basic EPS changing from ¥40.54 to ¥23.42 over the same period. This provides a backdrop for investors to weigh stronger full year earnings alongside how...

Money Forward, Inc. recently held board meetings to consider introducing a shareholder benefit program and issuing new shares as restricted stock compensation, alongside reporting its Q1 2026 results and hosting an earnings call on April 14, 2026. This combination of governance decisions and earnings disclosure highlights how Money Forward is using both capital allocation tools and investor incentives to shape its shareholder relations approach. Next, we'll examine how the anticipated...

In April 2026, Daiichi Sankyo and Merck reported that the FDA accepted and granted Priority Review to their Biologics License Application for ifinatamab deruxtecan for adults with extensive-stage small cell lung cancer progressing after platinum-based chemotherapy, with an FDA action date set for October 10, 2026. This Priority Review, alongside Breakthrough Therapy Designation and inclusion in programs like Real-Time Oncology Review and Project Orbis, underscores regulatory momentum for...

Seiko Epson (TSE:6724) has drawn fresh attention after unveiling the SureColor V4000 UV flatbed printer, an expansion of its V-Series line aimed at direct-to-object production across signage and promotional goods. See our latest analysis for Seiko Epson. The new printer launch comes as Seiko Epson’s share price has shown steady momentum, with a 30-day share price return of 4.68% and a 1-year total shareholder return of 14.66%, suggesting gradually improving sentiment around the stock. If this...

Wondering if Panasonic Holdings at ¥2,917.5 is offering fair value or asking you to pay up for past success? This breakdown is designed to help you frame that question clearly. The stock has recently posted returns of 2.9% over 7 days, 11.8% over 30 days, 40.4% year to date and 95.7% over 1 year, which puts recent price action front and center for anyone thinking about valuation. These moves sit alongside a longer record of 144.7% over 3 years and 141.5% over 5 years, which gives helpful...

On April 6, 2026, LY Corporation’s board met and later confirmed that Chairperson and Representative Director Kentaro Kawabe will retire when his current director term ends at the conclusion of the 31st Ordinary General Meeting of Shareholders scheduled for June 19, 2026. This leadership transition places succession planning and governance quality in the spotlight, potentially reshaping how investors view LY’s execution on its long-term platform and AI integration plans. We’ll now examine...

Shareholders of YASKAWA Electric Corporation ( TSE:6506 ) will be pleased this week, given that the stock price is up...

Index inclusion puts Pan Pacific International Holdings in focus Pan Pacific International Holdings (TSE:7532) has been added to the Nikkei 225 Index, a shift that often brings higher visibility, benchmark-linked demand, and fresh attention to trading volumes and valuation. See our latest analysis for Pan Pacific International Holdings. Recent price action has been mixed, with a 7.43% 90 day share price return and a 4.94% year to date share price return. The 1 year total shareholder return...

Earnings and Dividend Decision in Focus ABC-MartInc (TSE:2670) has drawn attention after reporting full year results to February 28, 2026, alongside a board meeting on April 8 to consider a dividend increase from surplus. The company reported annual sales of ¥378,624 million and net income of ¥46,346 million, with basic earnings per share from continuing operations at ¥187.17, compared with the prior year figures provided. See our latest analysis for ABC-MartInc. ABC-MartInc’s recent board...

Hisamitsu Pharmaceutical (TSE:4530) has reported its FY 2026 results with fourth quarter revenue of ¥48.5b and basic EPS of ¥103.57, alongside trailing 12 month revenue of ¥163.0b and EPS of ¥268.55 that frame the latest quarter in a wider context. The company has seen revenue move from ¥156.0b to ¥163.0b on a trailing 12 month basis, while trailing EPS shifted from ¥295.58 to ¥268.55, setting up a picture where top line progress sits alongside softer earnings and margins that investors may...

Nippon Steel stock: what recent returns say about investor sentiment Nippon Steel (TSE:5401) shares have seen mixed performance recently, with a 0.7% decline over the past day, a 1.6% gain over the past week, and a 9.7% decline over the past 3 months. See our latest analysis for Nippon Steel. At a share price of ¥595.8, Nippon Steel’s recent 1-day and 90-day share price declines contrast with its positive 1-year and 5-year total shareholder returns, suggesting shorter term momentum has faded...

Recently, failed US–Iran negotiations and the prospect of a US move to block the Strait of Hormuz pushed oil prices back above US$100, lifting many oil-related stocks including Japan Petroleum Exploration. This episode underlines how tightly Japan Petroleum Exploration’s outlook is tied to geopolitical flashpoints that can rapidly reshape global energy supply expectations. We will now examine how the jump in oil prices amid Middle East tensions may influence Japan Petroleum Exploration’s...

Recent share performance and business snapshot Ajinomoto (TSE:2802) has drawn fresh attention after a strong past 3 months in its share price, prompting investors to look more closely at how its core food and healthcare businesses are currently positioned. The company reports revenue of ¥1.54b and net income of ¥77,580m, with operations spanning seasonings and foods, frozen foods, and a healthcare and other segment that includes amino acids, materials and contract pharmaceutical services. See...

KDDI Corporation’s March 31, 2026 board meeting approved director nominations and followed the release of nine‑month results to December 31, 2025, showing higher sales of ¥4,471,796 million and net income of ¥545,541 million compared with a year earlier. On the same day, KDDI cut its full‑year guidance after uncovering inappropriate transactions at subsidiaries BIGLOBE and G‑PLAN, leading to loss recognition, an impairment charge of ¥50.00 billion, and planned management changes including...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Shareholders of Fast Retailing Co., Ltd. ( TSE:9983 ) will be pleased this week, given that the stock price is up 15...

In a board meeting held on April 10, 2026, Ryohin Keikaku announced record first-half revenue and profit growth, raising its full-year earnings outlook and annual dividend forecast while implementing a 2-for-1 stock split. The company linked its upgraded guidance and higher dividend to strong overseas performance, margin improvement, and the earnings impact of yen weakness, underscoring management’s emphasis on stable shareholder returns. We’ll now examine how Ryohin Keikaku’s upgraded...